# BridgeBio Oncology Therapeutics, Inc. (BBOT) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$146M |
| 2024 | -$81M |
| 2023 | -$65M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$46M |
| 2025-12-31 | -$43M |
| 2025-09-30 | -$49M |
| 2025-06-30 | -$30M |
| 2025-03-31 | -$23M |
| 2024-12-31 | -$22M |

Source: [CompaniesByCap](https://companiesbycap.com/company/BBOT/operating-income)